Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from the MHRA and NHS Health Research…
In the first double-blind, placebo-controlled trial, vaporised cannabis was found to be more effective for treating acute migraine symptoms than a placebo. While preclinical and retrospective…
